chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He got his vaccine, he had a fever after that.  Then about 2 years now mother is noticing stuttering, different styles of delayed when he's going too fast.  There is something not right with the bone, his right arm he keeps dislocating.  He has fallen 3 times on different occasions, one in 2021, February of 2022 he fell and dislocated his elbow on the right side.  Both times it has had to be put back into place.  Mother has been trying to get him into an Orthopedist, but has not been able to be seen to get some sort of brace for him.    Mother has not taken him to get any other vaccines due to these reactions.
Patient received first dose of COVID vaccine- Moderna. Patient is 16  years of age and should have received Pfizer. No side effect or reactions noted
Patient states after receiving the flu shot she has experienced swelling left arm up to upper shoulder above clavicle, pain, dizziness, loss of appetite, shortness of breath.
The evening and for sure the day following the pneumovac polysacc, my left arm started to become  red from the shot down the arm. The arm grew larger and tingled. I tried to ignore it. It finally became less swollen and red  and the tingling stopped, about a week later. I did not call my doctor, but I will email her now, so she can confirm I got the vaccine.
Initial report was received on 19 March 2012 from a health care professional. A cluster of two unidentified patient's who had no illness at the time of vaccination had received in March 2012 an intramuscular injection of ADACEL, lot number C4008BA (site and exact date of administration not reported) and an unspecified amount of time later developed cellulitis at the injection site with swelling, redness and pain. Both patients were evaluated in the emergency room (ER). One patient had been seen in follow-up and was "improving". No further information was available at the time of report. One patient was reported to have recovered and the other patient's recovery status was unknown. Documents held by sender: None.
Initial information has been received from physician via field representative concerning a 2 months old male patient with an unspecified pertinent medical history or drug reactions/allergies. On an unknown date, the patient was vaccinated with oral ROTATEQ (lot number 0577AE exp date October 2013) (dose, frequency and route were not reported). No other co-suspect medications were reported. No concomitant medications were reported. On 11-FEB-2013 the patient experienced vomiting. No treatment was reported. No laboratory studies were reported. At the time of report, the patient had not recovered. The patient sought medical attention by telephone contact. This is one of several reports from the same source. Additional information has been requested.
Patient initially developed erythema at injection site which resolved now over 4 months later patient presents to clinic with tender nodule 1 x 3 cm oval at left deltoid.
The patient presented to the ED with Shortness of Breath and Chest Tightness which started 24 hours after she received her first dose of the Pfizer Covid vaccine.  The patient received diphenhydramine IM for treatment of the adverse reaction.  Her symptoms improved and she was discharged from the ED.
Information has been received from a medical assistant concerning a 75 year old male patient who at 2 pm on 18-JUN-2008 inadvertently received a first dose of VARIVAX (Merck) (lot# 65875/1270U) in his left arm. The patient was intended to receive ZOSTAVAX (Merck). This was an administration error and not product confusion. No adverse symptoms reported. Additional information is not expected.
I arrived at the doctors office about 1 PM. I seen the doctor about 2 PM. About 30 minutes after I received the shot I started feeling really bad. I layed down thinking it would make me feel better. I woke up 12 hours later with my throat swollen and a high fever of 103. It has been three days and my throat still has not gone down all the way. My fever has gone away.
myopericarditis, admitted for chest pain/elevated troponins on 9/21/21, clinically stable, treating with aspirin/colchicine
spot is red now; spot is itchy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (spot is red now) and VACCINATION SITE PRURITUS (spot is itchy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (spot is red now) and VACCINATION SITE PRURITUS (spot is itchy). At the time of the report, VACCINATION SITE ERYTHEMA (spot is red now) and VACCINATION SITE PRURITUS (spot is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not reported.  Treatment details was not reported .  Post vaccination of 7 days patient experienced red and itchiness at injection site.
injected with shingrix reconstituted with sterile water; injected with shingrix reconstituted with sterile water; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate reconstitution technique in an unspecified number of patients who received Herpes zoster (Shingrix) (batch number 72p98, expiry date 9th April 2023) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate reconstitution technique and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate reconstitution technique and inappropriate dose of vaccine administered were unknown.  Additional details were reported as follows: Age at vaccination was not applicable as this scenario was related to several patients (approximately 5). The patients received a dose of Shingrix where it was reconstituted with sterile water, which led to Inappropriate dose of vaccine administered and Inappropriate reconstitution technique. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021252847:same reporter, duplicate,deleted case
20JUN96 pt noticed pain @ lt upper arm @ inj site;there was approx 3cm diameter redness;It remained sore during noc;pt also noticed 5-6 brief episodes of spasms to the jaw & the worried pt;redness dec 21JUN96 pt had limited motion;
positive for Covid; positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A 77-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization; elasomeran (COVID-19 VACCINE MODERNA), on 06Sep2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "unknown" and all described as "positive for Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06Sep2022) Negative, notes: On the day of the booster patient was Covid negative; (09Sep2022) Positive, notes: Doctor mentioned patient tested positive for Covid this morning; (Sep2022) Positive, notes: is positive for Covid, within 3 days of Covid booster.  Clinical course: Doctor stated, one of her patients got the booster dose 3 days ago and on the day of the booster patient was Covid negative. After the covid-19 vaccine, patient had symptoms of fever, myalgia and sore throat. Stated that, today 3 of his symptoms were getting worse and was positive for Covid, within 3 days of Covid booster. Caller asked, was it safe to give the patient Paxlovid. Caller asked, any contraindication to use Paxlovid along with vaccine within 3 days time. Doctor stated that, she needed to either send the prescription or decline. Caller mentioned that, she thought it was okay to give Paxlovid but unsure what other consequences within 3 days of Covid-19 vaccine. Caller mentioned that, most of her patients were vaccinated and she was writing vaccinations for them and that they were fine. Caller mentioned that, she did not had a case where in the symptom just appeared immediately after the vaccination then to give Paxlovid. It could be vaccine side effects that patient was reacting to it but tested positive. Caller was speaking quite fast and unclear on some parts. Stated that, patient was 77-year-old and had no kidney, liver problems. Stated that, patient had just got his covid vaccine a few days ago. Stated that, patient was on the other line and mentioned that he received his Moderna booster dose, that was his fifth shot/dose. Stated that, patient got Pfizer back in February when he started, then got his 3rd Moderna booster. Patient confirmed that, he got 2 Pfizer vaccine and Moderna booster. Doctor mentioned that patient tested positive for Covid this morning.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events Drug Ineffective and Covid-19 and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
6 YO patient developed a local allergic reaction at the administration site with erythema, moderate swelling, and drainage from bandage site. Hard to the touch on palpation. Sent to ER for treatment of cellulitis.
Moderate to severe local pain at injection site. Pain is more with this Moderna Covid-19 vaccination than any other vaccine I received in recent years. Pain is more when you move the arm.
Information has been received from a nurse concerning a female who in June 2007, was vaccinated with a dose of Gardasil. Subsequently the patient experienced nausea, soreness on the injection site arm and fever. Subsequently, the patient recovered from nausea, soreness on the injection site arm and fever. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash on arm and other spots of body), FATIGUE (fatigue) and CHILLS (chills) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced FATIGUE (fatigue) and CHILLS (chills). On 05-Apr-2021, the patient experienced RASH PRURITIC (itchy rash on arm and other spots of body). At the time of the report, RASH PRURITIC (itchy rash on arm and other spots of body), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported.
Narrative:  Patient received his second COVID booster on 4/8/22 with Moderna (SPIKEVAX) mRNA vaccine. He previously received primary series on 1/8/21 and 2/5/21, as well as first booster on 11/24/21, all with Moderna vaccine. No reported adverse reactions following those doses. On 4/10/22, his left arm was noted with swelling, redness and reported itching. Acetaminophen 650mg was administered with some documented relief of itching. Injection site still noted with redness and warmth. Cold compress was applied. Diphenhydramine 25mg was administered later that night (00:49). FNP evaluated site on morning of 4/11/22 and observed erythema, edema and warmth extending from shoulder to mid-upper arm. He wad diagnosed with cellulitis and started on renally-dosed sulfamethoxazole/trimethoprim. Close monitoring continues.
nerve pain; chills; he is unable to even stand or walk; he is unable to even stand or walk; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 56 year-old male patient received bnt162b2 (BNT162B2), administration date 19Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: Nov2020 (unspecified if ongoing); "diabetes causing high blood sugars" (unspecified if ongoing); "nerve damage" (unspecified if ongoing); "nerve pain" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: NEURALGIA (non-serious) with onset Mar2021, outcome "unknown", described as "nerve pain"; CHILLS (non-serious) with onset Mar2021, outcome "unknown", described as "chills"; DYSSTASIA (non-serious), GAIT DISTURBANCE (non-serious) all with onset Mar2021, outcome "unknown" and all described as "he is unable to even stand or walk". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller stated her son received the first dose of the Pfizer COVID vaccine yesterday. Caller stated her son had COVID-19 in Nov2020 and it accelerated his diabetes causing high blood sugars and caused nerve damage. Caller stated today her son had been experiencing nerve pain that he describes as the worst nerve pain he has ever had. Caller stated her son had nerve pain in the past, but he had been able to stand in the past but today the pain had been so excruciating that he was unable to even stand or walk. Caller stated he had also had chills. Caller would like to know if the vaccine could have aroused him immune system and caused him to have severe nerve pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
It was reported that a 20 year old female pt received Fluzone and Menomune at approximately 3:30pm on 11/5/02. The pt reportedly felt well prior to receiving vaccinations. At 8:30pm on 11/5/02, the pt experienced onset of slight headaches and slight stiff neck with muscular aching but without joint pain. The pt felt nauseated without vomiting, no nuchal rigidity but complained of slight pain with head flexion. The pt also experienced slight tenderness at upper arm. The reporter spike with pt by phone on 11/11/02 and she was asymptomatic by 11/9/02. Th pt was not on any other medications at time of vaccination and had no previous history of any medical conditions or allergies.
Information has been received from a company representative concerning his 14 year old son who was vaccinated with first dose of varicella virus vaccine live. Two-week post vaccination, the patient experienced pain and blistering at injection site. Additional information has been requested.
Local reaction 2" induration and 3 1/2" erythema at injection site (R) vastus lateralis. Tx with KEFLEX for early cellulitis.
23AUG94 pt recvd vax 23AUG94; mom states 6-8 hrs later pt had high pitched unconsolable crying, t101 but relieved by APAP given q 4-6 hrs; also bathed pt in tepid H20; mom reported crying better by late AM next day; temp remained 101;
Varicella vaccine breakthrough. On 06/19/2006, seen in office with over 100 lesions and diagnosed with varicella. No fever.
Patient reported swelling of eyes, lips and throat. She visited her primary physician and was treated with DECADRON and ALAVERT.
Systemic: Patients Period started 4/1 - wasn't supposed to start. Lasted for 15 days, even though normally only lasts 7 days-Medium
Initial report received from a health care professional (pharmacist) on 23 October 2014. A 43-years-old female patient, with no reported medical history, had received an intramuscular dose of FLUZONE QIV (batch number reported as U5196AE, which is not a valid lot number) in the left deltoid on 22 October 2014. She had none known allergies. On 22 October 2014, one hour post-vaccination, she experienced wheezing and hot flashes that lasted into the evening. At 6:30pm, the patient fainted and was taken to the Emergency room. It was stated that the ER diagnosis was "viral syndrome". She continued to experience fever and "not feeling well" on 23 October 2014. The patient had received vaccination through her employee health program, but vaccine was administered through the pharmacy which reported the events. It was not reported whether the patient had received any corrective or concomitant medications. At the time of the report, the patient was not recovered. Document held by sender: none.
The pt lost speech that had developed at 6 months. Became increasingly uncomfortable, arching back, and screaming for hours after a fever for 3 days following vaccination. FOLLOW-UP information received in an annual follow up report states, " Unable to attend, loss of concentration, uncoordinated, extreme temper, tantrums due to inability to communicate visual sensitive, audio sensitive, immune, system dysfunction." The annual follow-up states "unable to attend, loss of concentration, uncoordinated extreme temper tantrums due to inability to communicate, visual sensitive, audio sensitive, immune sytem dysfunction. This doctor did not react when I had concern. Infact, he almost vaccinated my child again one momth later until I stopped him and seeked better care. My child has suffered and my family has suffered ever since that day. Residual effects are my son had decreased blood flow to the social/comunication part of the brain because of a viral infection he caught when his immune system was compromised from the vaccines. The symptoms were "mimicking autism" and he was diagnosed as such by three doctors, all neuro-pediatricians. MD found the viral infection my son's weakened immune system could not fight."
booster shot 0.25ml post pfizer primary series Red swollen arm began around noon of the same day, redness and pain continued for 5 days, began to reduce on 1/11 but then face began to swell slightly and had redness beginning. Patient was advised to seek treatment if possible due to facial swelling but was not interested, advised to continue antihistamine that had reduced swelling in arm but to seek medical attention as soon as any worsening occurred. Patient familiar with anaphylactic reactions due to macrobid allergy and will monitor self closely.
No ADR Staff stated he needed to receive 2nd dose of COVID vaccine. It was later noted he had already received the 2nd dose and a 1st booster dose already.
Spreading rash hot to the touch. Now my son stutters when he speaks. He has never stuttered before. I thought this might self correct but it has continued.
3 1/2 cm x 3 1/2 cm induration at vaccine site;  warm to touch.  BENADRYL 25 mg po q 6 hours ordered by Dr.
Rash started 8 days after receiving MMR. Child presents with macular-papular rash  with various sizes on trunk and face. Temp.102, fussy, sleeping a lot.
One of the patients got 2 doses of Moderna Bivalent vaccine; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXTRA DOSE ADMINISTERED (One of the patients got 2 doses of Moderna Bivalent vaccine) and NO ADVERSE EVENT (no adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (One of the patients got 2 doses of Moderna Bivalent vaccine) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (One of the patients got 2 doses of Moderna Bivalent vaccine) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (One of the patients got 2 doses of Moderna Bivalent vaccine).    No concomitant medications were reported.   No treatment details were reported.
this nursing home pt devel a sl inj site rxn p/vax;this is 1of 2 reports from this facility of inj site rxn p/vax;
Aug- Sep90 pt vax; devel measles,  Dx was not confirmed by lab analysis.
pt recv vax 20FEB97 & had sl upper resp infect;mom reports elevated temp that noc approx 10hr p/vax;given APAP (did not actually take temp);pt stared & jerked upper extremities;mom did not seek med eval;
Pt recv vax on 11/17/98; on 11/18/98 pt exp redness, soreness, swelling & heat of vax site; joint pain, chills, fever x 2 day
Information has been received from a physician concerning a 12 month old female (also reported as male) with a history of anemia who on approximately 09Feb2004 was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccination included a dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). On approximately 20Feb04, a complete blood cell count was dose as a follow up to the child's prior history of anemia. The laboratory results showed a platelet count of only 700/microliter and 6 atypical lymphocytes. Unspecified medical attention was sought and a prescription drug was not required. A product quality complaint was not involved. Additional information was received from the physician who indicated that the vaccination seemed to cause an increase in platelets and atypical lymphocytopenia. He stated that her platelet count was 700,000. The physician noted that the pt was doing fine post vaccination and the laboratory tests were performed to follow up due to the anemia and to test for lead. Since she had no other viral symptoms he felt that it was from the live virus vaccines. The reporter was looking more at varicella virus vaccine live since the laboratory test was two weeks post vaccination, and the natural cycle of chickenpox falls within that time frame. He also noted that the pt was completely asymptomatic and was doing great. He planned to repeat the labs in a couple months. Additional information has been requested.